{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:45:01Z","timestamp":1785437101663,"version":"3.56.0"},"reference-count":18,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"WHO"},{"id":[{"id":"https:\/\/ror.org\/01f80g185","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Equity is fundamental to an effective pandemic vaccination response, yet the COVID-19 pandemic demonstrated how inequitable access, driven by purchasing power and delayed supply for low- and middle-income countries (LMICs), prolonged transmission and enabled viral evolution. The Pandemic Influenza Preparedness (PIP) Framework offers a model for providing timely and equitable access to pandemic influenza vaccines. Through legally binding advance supply agreements, the PIP Framework secures real-time access by the WHO to a proportion of global vaccine production and mandates allocation based on public health risk and need. In doing so, it addresses the two axes of inequity observed in previous pandemics\u2014distribution and timeliness\u2014by ensuring that affected populations that do not have access, irrespective of income status, are not at the back of the queue.<\/jats:p>","DOI":"10.3390\/vaccines14080653","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:38:41Z","timestamp":1784889521000},"page":"653","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Equity and Pandemic Influenza Vaccine Response: The PIP Framework as a Model for an Efficient Pandemic Influenza Response Through Equitable Vaccine Access"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1021-1037","authenticated-orcid":false,"given":"Kate S.","family":"Rawlings","sequence":"first","affiliation":[{"name":"World Health Emergencies Program, World Health Organization (WHO), 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kim","sequence":"additional","affiliation":[{"name":"World Health Emergencies Program, World Health Organization (WHO), 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Huvos","sequence":"additional","affiliation":[{"name":"World Health Emergencies Program, World Health Organization (WHO), 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Jamison, D.T., Gelband, H., Horton, S., Jha, P., Laxminarayan, R., Mock, C.N., and Nugent, R. (2017). Pandemics: Risks, Impacts, and Mitigation. Disease Control Priorities: Improving Health and Reducing Poverty, The International Bank for Reconstruction and Development\/The World Bank.","DOI":"10.1596\/978-1-4648-0527-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/cir007","article-title":"\u201cHerd Immunity\u201d: A Rough Guide","volume":"52","author":"Fine","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","unstructured":"Orenstein, W.A., Offit, P.A., Edwards, K.M., and Plotkin, S.A. (2023). Plotkin\u2019s Vaccines, Elsevier."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Cao, W., Zhu, J., Wang, X., Tong, X., Tian, Y., Dai, H., and Ma, Z. (2022). Optimizing Spatio-Temporal Allocation of the COVID-19 Vaccine Under Different Epidemiological Landscapes. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.921855"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20210709","DOI":"10.1098\/rsif.2021.0709","article-title":"Evaluating Strategies for Spatial Allocation of Vaccines Based on Risk and Centrality","volume":"19","author":"Singer","year":"2022","journal-title":"J. R. Soc. Interface"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41577-021-00544-9","article-title":"Concerns about SARS-CoV-2 Evolution Should Not Hold Back Efforts to Expand Vaccination","volume":"21","author":"Cobey","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","unstructured":"Mathieu, E., Ritchie, H., Rod\u00e9s-Guirao, L., Appel, C., Gavrilov, D., Giattino, C., Hasell, J., Macdonald, B., Dattani, S., and Beltekian, D. (2020). Coronavirus (COVID-19) Vaccinations. Our World Data, Available online: https:\/\/archive.ourworldindata.org\/20260722-064056\/covid-vaccinations.html."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41562-022-01289-8","article-title":"Equitable Access to COVID-19 Vaccines Makes a Life-Saving Difference to All Countries","volume":"6","author":"Ye","year":"2022","journal-title":"Nat. Hum. Behav."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41467-023-39098-w","article-title":"Estimating the Impact of COVID-19 Vaccine Inequities: A Modeling Study","volume":"14","author":"Gozzi","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41591-022-02064-y","article-title":"Retrospectively Modeling the Effects of Increased Global Vaccine Sharing on the COVID-19 Pandemic","volume":"28","author":"Moore","year":"2022","journal-title":"Nat. Med."},{"key":"ref_11","unstructured":"World Health Organization (2026, January 20). Achieving 70% COVID-19 Immunization Coverage by Mid-2022. Available online: https:\/\/www.who.int\/news\/item\/23-12-2021-achieving-70-covid-19-immunization-coverage-by-mid-2022."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e012168","DOI":"10.1136\/bmjgh-2023-012168","article-title":"A Critical Analysis of COVAX Alliance and Corresponding Global Health Governance and Policy Issues: A Scoping Review","volume":"8","author":"Pushkaran","year":"2023","journal-title":"BMJ Glob. Health"},{"key":"ref_13","unstructured":"World Health Organization (2021). Pandemic Influenza Preparedness (PIP) Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits, World Health Organization. [2nd ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"126839","DOI":"10.1016\/j.vaccine.2025.126839","article-title":"Global Production Capacity of Seasonal and Pandemic Influenza Vaccines in 2023","volume":"51","author":"Taaffe","year":"2025","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Baylor, N.W., and Goodman, J.L. (2022). Vaccine Preparedness for the Next Influenza Pandemic: A Regulatory Perspective. Vaccines, 10.","DOI":"10.3390\/vaccines10122136"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1440-1843.2011.02003.x","article-title":"Pandemic Response Lessons from Influenza H1N1 2009 in Asia","volume":"16","author":"Fisher","year":"2011","journal-title":"Respirology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-2659.2009.00085.x","article-title":"Pandemic Influenza Vaccines: Meeting the Supply, Distribution and Deployment Challenges","volume":"3","author":"Hessel","year":"2009","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_18","unstructured":"World Health Organization (2023). Pandemic Influenza Preparedness Framework: Partnership Contribution High-Level Implementation Plan III 2024\u20132030, World Health Organization. [1st ed.]."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/8\/653\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:22:49Z","timestamp":1785039769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/8\/653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["vaccines14080653"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14080653","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}